Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Arrowhead Pharmaceuticals (ARWR) has a market cap of $1.77 billion USD. According to our data, Arrowhead Pharmaceuticals is ranked No.4172 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.77 B |
-24.84%
|
| Dec 31, 2024 | $2.35 B |
-38.56%
|
| Dec 29, 2023 | $3.83 B |
-24.56%
|
| Dec 30, 2022 | $5.07 B |
-38.82%
|
| Dec 31, 2021 | $8.29 B |
-13.59%
|
| Dec 31, 2020 | $9.60 B |
20.97%
|
| Dec 31, 2019 | $7.93 B |
410.71%
|
| Dec 31, 2018 | $1.55 B |
237.50%
|
| Dec 29, 2017 | $0.46 B |
137.42%
|
| Dec 30, 2016 | $0.19 B |
-74.80%
|
| Dec 31, 2015 | $0.77 B |
-16.67%
|
| Dec 31, 2014 | $0.92 B |
-31.98%
|
| Dec 31, 2013 | $1.36 B |
407.01%
|
| Dec 31, 2012 | $0.27 B |
-48.93%
|
| Dec 30, 2011 | $0.52 B |
-53.18%
|
| Dec 31, 2010 | $1.12 B |
68.87%
|
| Dec 31, 2009 | $0.66 B |
-42.39%
|
| Dec 31, 2008 | $1.15 B |
-75.66%
|
| Dec 31, 2007 | $4.73 B |
-13.70%
|
| Dec 29, 2006 | $5.48 B |
3.06%
|
| Dec 30, 2005 | $5.32 B |
-1.62%
|
| Dec 31, 2004 | $5.40 B |
232.31%
|
| Dec 31, 2003 | $1.63 B |
233.33%
|
| Dec 31, 2002 | $0.49 B |
-60.00%
|
| Dec 31, 2001 | $1.22 B |
-75.81%
|
| Dec 29, 2000 | $5.04 B |
12.73%
|
| Dec 31, 1999 | $4.47 B |
-31.25%
|
| Dec 31, 1998 | $6.50 B |
60.00%
|
| Dec 31, 1997 | $4.06 B |
-67.95%
|
| Dec 31, 1996 | $12.68 B |
-37.60%
|
| Dec 29, 1995 | $20.32 B |
257.14%
|
| Dec 30, 1994 | $5.69 B |
-97.45%
|
| Dec 31, 1993 | $223.57 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 BioNTech
BNTX
|
$23.80 B |
0.001 M
|
Germany
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
| Market Cap | = | ARWR Stock Price | * | ARWR Shares Outstanding |
| = | $12.87 | * | 0.14 B | |
| = | $1.77 B |